Additional file 2: Table S2. of Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma

Overman, Michael; Soifer, Harris; Schueneman, Aaron; Ensor, Joe; Adsay, Volkan; Saka, Burcu; Neishaboori, Nastaran; Wolff, Robert; Wang, Huamin; Schnabel, Catherine; Varadhachary, Gauri

doi:10.6084/m9.figshare.c.3606641_D1.v1

12885_2016_2677_MOESM2_ESM.docx (29.15 kB)

Additional file 2: Table S2. of Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma

journal contribution

posted on 2016-08-22, 05:00 authored by Michael Overman, Harris Soifer, Aaron Schueneman, Joe Ensor, Volkan Adsay, Burcu Saka, Nastaran Neishaboori, Robert Wolff, Huamin Wang, Catherine Schnabel, Gauri Varadhachary

Clinicopathological features of ampullary adenocarcinomas with histologies that are different from their survival groups in the 3-gene model. Abbreviations: OS, overall survival. 1T stage, N = 53, one case was carcinoma in situ; 2Positive CDX2 expression was defined as modified H score > 35; 3Positive MUC1 expression was defined as any positive staining. (DOCX 30 kb)